SAB Biotherapeutics, Inc. (SABSW) › Shareholders' EquitySAB Biotherapeutics, Inc. (SABSW) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $7.69M2020: $39.01M2021: $38.55M2022: $31.06M2023: $57.30M2024: $25.97M2025: $151.49M$151.49M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$151.49M+483.4%2024$25.97M-54.7%2023$57.30M+84.5%2022$31.06M-19.4%2021$38.55M-1.2%2020$39.01M+407.0%2019$7.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share